Position in BTAI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$63
+$3 QoQ
Shares Held
45
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 47 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. BTAI ranks #60 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in BTAI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63 | 45 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $60 | 45 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $72 | 45 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $115 | 45 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $81 | 45 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $235 | 116 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $496 | 1,328 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $456 | 749 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $958 | 749 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $25,199 | 8,936 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $37,473 | 12,703 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $32,404 | 12,808 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $142,790 | 21,440 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $322,648 | 17,291 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $246,806 | 11,595 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $125,161 | 10,589 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $136,989 | 10,378 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $284,501 | 13,606 | Shares | Defined | 2022-05-11 | |
| 2021-09-30 | $332,423 | 10,953 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $275,517 | 9,481 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $354,428 | 8,212 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $268,282 | 5,807 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $189,699 | 4,375 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $188,980 | 3,565 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $49,661 | 2,222 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||